Skip to content
AwardedPOLGoods

Dzierżawa trzech analizatorów parametrów krytycznych wraz z dostawą odczynników i materiałów zużywalnych dla Szpitala Praskiego p.w. Przemienienia Pańskiego Sp. z o.o. w Warszawie

Published
Published 3 March 2026
Deadline
Closed 8 April 2026

Overview

Szpital Praski p.w. Przemienienia Pańskiego procures a three-year lease of three critical parameter analyzers along with delivery of reagents and consumable materials. The contract was awarded to Werfen Polska Sp. z o.o. for 432,649.2 PLN on 23 April 2026, with all deliveries required to meet EU standards and include Polish-language documentation and labeling.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
SME suitable
No
Published
3 March 2026
Deadline
Closed
Classification (CPV)
Blood analysers

Award outcome

Awarded value
PLN 432,649
Award date
23 April 2026
Contract period
— → 12 April 2028
Winner
  • Werfen Polska Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    28 April 2026

  2. Contract Notice

    30 March 2026

  3. Contract Notice

    3 March 2026

Contracting authority

  • SZPITAL PRASKI P.W. PRZEMIENIENIA PAŃSKIEGO SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

    Procuring entity

    Warszawa, POL

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dzierżawa trzech analizatorów parametrów krytycznych wraz z dostawą odczynników i materiałów zużywalnych dla Szpitala Praskiego p.w. Przemienienia Pańskiego Sp. z o.o. w Warszawie — won by Werfen Polska Sp. z o.o. — Skim